Corcept Therapeutics (CORT) Interest Coverage Ratio (2010 - 2026)
Corcept Therapeutics (CORT) reported Interest Coverage Ratio of 4.32 for Q1 2026, down 1173.11% on a YoY basis from 0.4 in Q1 2025, and down 100.19% sequentially from 2243.5 in Q4 2025.
Corcept Therapeutics (CORT) Interest Coverage Ratio (2010 - 2026) Analysis & Trends
Corcept Therapeutics (CORT) has 17 years of Interest Coverage Ratio data on file, last reported at 4.32 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 1173.11% year-over-year to 4.32; the trailing twelve-month figure through Mar 2026 stood at 0.72 (down 105.48% YoY), and the FY2025 full-year result was 192.26, up 212.78% from the prior year.
- Interest Coverage Ratio eased to 4.32 in Q1 2026, from 2243.5 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 2243.5 in Q4 2025 to a low of 4.32 in Q1 2026.
- A 5-year average of 141.41 and a median of 3.88 in 2022 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio jumped 4598.01% in 2025 and sank 1173.11% in 2026, its largest moves.
- Tracing CORT's Interest Coverage Ratio over 5 years: stood at 9.93 in 2022, then soared by 33.34% to 13.25 in 2023, then jumped by 260.54% to 47.75 in 2024, then surged by 4598.01% to 2243.5 in 2025, then tumbled by 100.19% to 4.32 in 2026.
- Business Quant data shows CORT's Interest Coverage Ratio at 4.32 in Q1 2026, 2243.5 in Q4 2025, and 1.32 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -0.38 |
| 10 | Corcept Therapeutics | 9.99 Bn | 9.65 Bn | 162.02 Mn | -4.32 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.32 |
| Dec 31, 2025 | 2,243.50 |
| Sep 30, 2025 | 1.32 |
| Jun 30, 2025 | 16.21 |
| Mar 31, 2025 | 0.40 |
| Dec 31, 2024 | 47.75 |
| Sep 30, 2024 | 5.34 |
| Jun 30, 2024 | 4.08 |
| Mar 31, 2024 | 47.81 |
| Dec 31, 2023 | 13.25 |
| Sep 30, 2023 | 3.00 |
| Jun 30, 2023 | 2.99 |
| Mar 31, 2023 | 1.60 |
| Dec 31, 2022 | 9.93 |
| Sep 30, 2022 | 3.80 |
| Jun 30, 2022 | 3.88 |
| Mar 31, 2022 | 3.48 |
| Dec 31, 2021 | 509.22 |
| Sep 30, 2021 | 5.03 |
| Jun 30, 2021 | 4.77 |